Table 1 Network meta-analysis for clinical pregnancy comparing diverse uterine infusion strategies

Control

2.76 (1.16, 5.81)

1.36 (0.64, 2.64)

2.58 (1.90, 3.43)

3.34 (1.38, 8.19)

2.80 (1.14, 6.60)

2.27 (1.76, 3.01)

3.03 (2.42, 4.07)

3.07 (2.30, 3.88)

2.90 (1.19, 10.06)

1.51 (0.41, 4.59)

1.59 (1.18, 2.06)

DEX

0.46 (0.17, 1.47)

0.88 (0.41, 2.35)

1.16 (0.39, 4.34)

0.95 (0.32, 3.44)

0.83 (0.37, 2.07)

1.11 (0.52, 2.80)

1.09 (0.49, 2.67)

1.09 (0.31, 5.09)

0.49 (0.13, 2.06)

0.56 (0.25, 1.43)

ECS

1.89 (0.90, 4.28)

2.46 (0.86, 7.94)

2.17 (0.66, 6.45)

1.67 (0.83, 3.81)

2.22 (1.14, 5.23)

2.40 (1.07, 4.94)

2.22 (0.74, 9.51)

1.08 (0.25, 4.05)

1.17 (0.56, 2.55)

G-CSF

1.31 (0.54, 3.18)

1.11 (0.46, 2.55)

0.89 (0.66, 1.29)

1.19 (0.89, 1.75)

1.23 (0.79, 1.71)

1.16 (0.45, 3.97)

0.60 (0.15, 1.99)

0.62 (0.46, 0.85)

G-CSF + AXaIUsc

0.87 (0.25, 2.65)

0.64 (0.28, 1.72)

0.89 (0.38, 2.33)

0.94 (0.35, 2.24)

0.87 (0.25, 3.84)

0.45 (0.09, 1.98)

0.48 (0.19, 1.15)

GH

0.79 (0.35, 2.09)

1.08 (0.47, 2.85)

1.13 (0.43, 2.68)

1.05 (0.33, 4.68)

0.51 (0.10, 2.40)

0.56 (0.23, 1.38)

HCG

1.36 (1.00, 1.89)

1.35 (0.88, 1.98)

1.26 (0.51, 4.43)

0.66 (0.17, 2.04)

0.69 (0.51, 0.89)

PBMC

1.00 (0.67, 1.36)

0.95 (0.37, 3.27)

0.50 (0.12, 1.54)

0.52 (0.37, 0.67)

PRP

0.96 (0.36, 3.47)

0.44 (0.13, 1.54)

0.49 (0.37, 0.76)

PRP + G-CSF

0.50 (0.07, 2.02)

0.53 (0.15, 1.37)

PRP + G-CSFsc

1.06 (0.32, 3.93)